{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:09:19Z","timestamp":1791464959143,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG 079189"],"award-info":[{"award-number":["AG 079189"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG 029479"],"award-info":[{"award-number":["AG 029479"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG 077700"],"award-info":[{"award-number":["AG 077700"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007306","name":"Arizona Department of Health Services","doi-asserted-by":"publisher","award":["211002"],"award-info":[{"award-number":["211002"]}],"id":[{"id":"10.13039\/100007306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U24 NS072026"],"award-info":[{"award-number":["U24 NS072026"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P30 AG19610"],"award-info":[{"award-number":["P30 AG19610"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008476","name":"University of California, Irvine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["1001"],"award-info":[{"award-number":["1001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["0011"],"award-info":[{"award-number":["0011"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["05-901"],"award-info":[{"award-number":["05-901"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","award":["4001"],"award-info":[{"award-number":["4001"]}],"id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.brainres.2025.149600","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:03:49Z","timestamp":1743185029000},"page":"149600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Reduction in [18F]Nifene Binding, a PET imaging Probe for \u03b14\u03b22* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer\u2019s disease brain"],"prefix":"10.1016","volume":"1857","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3104-9523","authenticated-orcid":false,"given":"Fariha","family":"Karim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6993-9131","authenticated-orcid":false,"given":"Allyson","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram B.","family":"Danh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-294X","authenticated-orcid":false,"given":"Christopher","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-877X","authenticated-orcid":false,"given":"Jogeshwar","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/0118744710314668240718070109","article-title":"Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine","volume":"18","author":"Aghahosseini","year":"2024","journal-title":"Current Radiopharmaceuticals"},{"key":"10.1016\/j.brainres.2025.149600_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110993","article-title":"Shedding light on subiculum\u2019s role in human brain disorders","volume":"214","author":"Baset","year":"2024","journal-title":"Brain Research Bulletin"},{"issue":"4","key":"10.1016\/j.brainres.2025.149600_b0015","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.brainres.2025.149600_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nucmedbio.2017.08.001","article-title":"Human biodistribution and dosimetry of [18F]nifene, an \u03b14\u03b22* nicotinic acetylcholine receptor PET tracer","volume":"55","author":"Betthauser","year":"2017","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.brainres.2025.149600_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jlcr.4071","article-title":"A simplified protocol for the automated production of 2-[18F]fluoro-3[2-((S)-3-pyrrolinyl)methoxy]pyridine ([18F]nifene) on an IBA Synthera module","volume":"67","author":"Bhuiyan","year":"2024","journal-title":"J. Labelled Compds Radiopharmaceuticals"},{"issue":"5","key":"10.1016\/j.brainres.2025.149600_b0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/syn.21530","article-title":"Nicotinic acetylcholine receptors in rat forebrain that bind 18F-nifene: Relating PET imaging, autoradiography, and behavior","volume":"66","author":"Bieszczad","year":"2012","journal-title":"Synapse"},{"issue":"23","key":"10.1016\/j.brainres.2025.149600_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237360","article-title":"[18F]Nifene PET\/CT Imaging in Mice: Improved Methods and Preliminary Studies of \u03b14\u03b22* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of \u03b1-Synucleinopathy and Post-Mortem Human Parkinson\u2019s Disease","volume":"26","author":"Campoy","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/JGP.0b013e3181b972aa","article-title":"Nicotinic 123I-5IA-85380 Single Photon Emission Computed Tomography as a Predictor of Cognitive Progression in Alzheimer\u2019s Disease and Dementia With Lewy Bodies","volume":"18","author":"Colloby","year":"2010","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"10","key":"10.1016\/j.brainres.2025.149600_b0060","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2967\/jnumed.117.205492","article-title":"18F-XTRA PET for Enhanced Imaging of the Extrathalamic \u03b14\u03b22 Nicotinic Acetylcholine Receptor","volume":"59","author":"Coughlin","year":"2018","journal-title":"Journal of Nuclear Medicine"},{"issue":"4589","key":"10.1016\/j.brainres.2025.149600_b0065","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s Disease: A Disorder of Cortical Cholinergic Innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"issue":"40","key":"10.1016\/j.brainres.2025.149600_b0070","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1523\/JNEUROSCI.3242-07.2007","article-title":"Hippocampal \u03b14\u03b22 Nicotinic Acetylcholine Receptor Involvement in the Enhancing Effect of Acute Nicotine on Contextual Fear Conditioning","volume":"27","author":"Davis","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.brainres.2025.149600_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegeneration"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/syn.20338","article-title":"Effect of acetylcholinesterase inhibitors on the binding of nicotinic \u03b14\u03b22 receptor PET radiotracer, 18F-nifene: A measure of acetylcholine competition","volume":"61","author":"Easwaramoorthy","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2025.149600_b0085","doi-asserted-by":"crossref","unstructured":"Ellis, J. R., Nathan, P. J., Villemagne, V. L., Mulligan, R. S., Ellis, K. A., Tochon-Danguy, H. J., Chan, J. G., O\u2019keefe, G. J., Bradley, J., Savage, G., & Rowe, C. C. (2009). The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[18F]fluoro-A-85380. Synapse, 63(9), 752\u2013763. https:\/\/doi.org\/10.1002\/syn.20642.","DOI":"10.1002\/syn.20642"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00213-008-1347-9","article-title":"Galantamine-induced improvements in cognitive function are not related to alterations in \u03b14\u03b22 nicotinic receptors in early Alzheimer\u2019s disease as measured in vivo by 2-[18F]Fluoro-A-85380 PET","volume":"202","author":"Ellis","year":"2009","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149600_b0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nlm.2008.05.006","article-title":"Relationship between nicotinic receptors and cognitive function in early Alzheimer\u2019s disease: A 2-[18F]fluoro-A-85380 PET study","volume":"90","author":"Ellis","year":"2008","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.brainres.2025.149600_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2019.00099","article-title":"Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer\u2019s Disease","volume":"13","author":"Furcila","year":"2019","journal-title":"Frontiers in Neuroanatomy"},{"issue":"2","key":"10.1016\/j.brainres.2025.149600_b0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2009.10.086","article-title":"Voxel-based assessment of gray and white matter volumes in Alzheimer\u2019s disease","volume":"468","author":"Guo","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"12","key":"10.1016\/j.brainres.2025.149600_b0110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/syn.21698","article-title":"PET imaging of acetylcholinesterase inhibitor-induced effects on \u03b14\u03b22 nicotinic acetylcholine receptor binding","volume":"67","author":"Hillmer","year":"2013","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.brainres.2025.149600_b0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/jpn.0442","article-title":"Interactions between \u03b2-amyloid and central cholinergic neurons: Implications for Alzheimer\u2019s disease","volume":"29","author":"Kar","year":"2004","journal-title":"Journal of Psychiatry and Neuroscience"},{"key":"10.1016\/j.brainres.2025.149600_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128164","article-title":"Development and evaluation of [18F]Flotaza for A\u03b2 plaque imaging in postmortem human Alzheimer\u2019s disease brain","volume":"46","author":"Kaur","year":"2021","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"8","key":"10.1016\/j.brainres.2025.149600_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/syn.21981","article-title":"[18F]Nifene test\u2013retest reproducibility in first-in-human imaging of \u03b14\u03b22* nicotinic acetylcholine receptors","volume":"71","author":"Lao","year":"2017","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.brainres.2025.149600_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22265","article-title":"Abnormal [18F]Nifene binding in transgenic 5xFAD mouse model of Alzheimer\u2019s disease: In vivo PET\/CT imaging studies of \u03b14\u03b22* nicotinic acetylcholinergic receptors and in vitro correlations with A\u03b2 plaques","volume":"77","author":"Liang","year":"2023","journal-title":"Synapse"},{"issue":"22","key":"10.1016\/j.brainres.2025.149600_b0140","doi-asserted-by":"crossref","first-page":"R1225","DOI":"10.1016\/j.cub.2017.09.042","article-title":"Memory retrieval: Taking the route via subiculum","volume":"27","author":"Lederberger","year":"2017","journal-title":"Current Biology"},{"key":"10.1016\/j.brainres.2025.149600_bib322","doi-asserted-by":"crossref","first-page":"121092","DOI":"10.1016\/j.neuroimage.2025.121092","article-title":"Disruption of normal brain distribution of [18F] Nifene to \u03b14\u03b22* nicotinic acetylcholinergic receptors in old B6129SF2\/J mice and transgenic 3xTg-AD mice model of Alzheimer\u2019s disease: In Vivo PET\/CT imaging studies","volume":"309","author":"Liang","year":"2025","journal-title":"NeuroImage"},{"key":"10.1016\/j.brainres.2025.149600_b0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2014.11.018","article-title":"Role of the nicotinic acetylcholine receptor in Alzheimer\u2019s disease pathology and treatment","volume":"96","author":"Lombardo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2025.149600_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149600_b0155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.2000.0721161.x","article-title":"Neuronal Nicotinic Receptor Deficits in Alzheimer Patients with the Swedish Amyloid Precursor Protein 670\/671 Mutation","volume":"72","author":"Marutle","year":"1999","journal-title":"Journal of Neurochemistry"},{"issue":"7","key":"10.1016\/j.brainres.2025.149600_b0160","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1074\/jbc.M116.764183","article-title":"A4b2 nicotinic acetylcholine receptors: Relationships between subunit stoichiometry and function at the single channel level","volume":"292","author":"Mazzaferro","year":"2017","journal-title":"J. Biol. Chem.,"},{"key":"10.1016\/j.brainres.2025.149600_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/imag_a_00397","article-title":"Age- and sex-related differences in human \u03b14\u03b22* nicotinic acetylcholine receptor binding evaluated with [18F]nifene PET","volume":"2","author":"McVea","year":"2024","journal-title":"Imaging Neuroscience"},{"key":"10.1016\/j.brainres.2025.149600_b0170","unstructured":"Meyer, P. M., Tiepolt, S., Barthel, H., Hesse, S., & Sabri, O. (2014). Radioligand imaging of \u03b14\u03b22* nicotinic acetylcholine receptors in Alzheimer\u2019s disease and Parkinson\u2019s disease. The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society Of..., 58(4), 376\u2013386."},{"issue":"Spec 6\/1","key":"10.1016\/j.brainres.2025.149600_b0045","first-page":"546","article-title":"Biomarkers for Alzheimer\u2019s disease. Where we stand and where we are headed","volume":"79","author":"Mendez","year":"2019","journal-title":"Medicina"},{"issue":"9","key":"10.1016\/j.brainres.2025.149600_b0175","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.neurobiolaging.2007.12.008","article-title":"Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT","volume":"30","author":"Mitsis","year":"2009","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1016\/j.brainres.2025.149600_b0180","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2967\/jnumed.109.064030","article-title":"123I-5-IA-85380 SPECT Imaging of Nicotinic Receptors in Alzheimer Disease and Mild Cognitive Impairment","volume":"50","author":"Mitsis","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.brainres.2025.149600_b0185","doi-asserted-by":"crossref","unstructured":"Mondal, R., Sandhu, Y. K., Kamalia, V. M., Delaney, B. A., Syed, A. U., Nguyen, G. A. H., Moran, T. R., Limpengco, R. R., Liang, C., & Mukherjee, J. (2023). Measurement of A\u03b2 Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer\u2019s Disease Brain by Autoradiography Using [18F]Flotaza, [125I]IBETA, [124\/125I]IPPI and Immunohistochemistry Analysis Using QuPath. Biomedicines, 11(4), Article 4. https:\/\/doi.org\/10.3390\/biomedicines11041033.","DOI":"10.3390\/biomedicines11041033"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cne.24320","article-title":"Human brain imaging of nicotinic acetylcholine \u03b14\u03b22* receptors using [18F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways","volume":"526","author":"Mukherjee","year":"2018","journal-title":"Journal of Comparative Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0200","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22183","article-title":"Development and evaluation of [125I]IPPI for Tau imaging in postmortem human Alzheimer\u2019s disease brain","volume":"75","author":"Mukherjee","year":"2021","journal-title":"Synapse (new York, n.y.),"},{"issue":"Pt B","key":"10.1016\/j.brainres.2025.149600_b0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuropharm.2014.10.021","article-title":"The nicotinic cholinergic system function in the human brain","volume":"96","author":"Nees","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2025.149600_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.0b013e31823efcbb","article-title":"Nicotine treatment of mild cognitive impairment","volume":"78","author":"Newhouse","year":"2012","journal-title":"Neurology"},{"issue":"suppl 7","key":"10.1016\/j.brainres.2025.149600_b0215","article-title":"Long term nicotine treatment of mild cognitive impairment (The MIND study): Baseline characteristics and study progress","volume":"19","author":"Newhouse","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_bib325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/receptors4010007","article-title":"Evaluation of [125I]\u03b1-bungarotoxin binding to \u03b17 nicotinic acetylcholinergic receptors in hippocampus\u2013subiculum of postmortem human alzheimer\u2019s disease brain","volume":"4","author":"Ngo","year":"2025","journal-title":"Receptors"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-0186(94)90059-0","article-title":"Human nicotinic receptors\u2014Their role in aging and dementia","volume":"25","author":"Nordberg","year":"1994","journal-title":"Neurochemistry International"},{"issue":"10","key":"10.1016\/j.brainres.2025.149600_b0225","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/brain\/awt195","article-title":"Alterations in \u03b14\u03b22 nicotinic receptors in cognitive decline in Alzheimer\u2019s aetiopathology","volume":"136","author":"Okada","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.brainres.2025.149600_b0230","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0022-3565(24)38304-1","article-title":"Increased nicotinic receptors in brains from smokers: Membrane binding and autoradiography studies","volume":"289","author":"Perry","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.brainres.2025.149600_b0235","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/neu.10102","article-title":"Nicotinic receptors in aging and dementia","volume":"53","author":"Picciotto","year":"2002","journal-title":"Journal of Neurobiology"},{"issue":"3","key":"10.1016\/j.brainres.2025.149600_b0240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nucmedbio.2005.12.017","article-title":"Nicotinic \u03b14\u03b22 receptor imaging agents: Part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate","volume":"33","author":"Pichika","year":"2006","journal-title":"Nuclear Medicine and Biology"},{"issue":"6","key":"10.1016\/j.brainres.2025.149600_b0245","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/brain\/awy099","article-title":"Cognitive correlates of \u03b14\u03b22 nicotinic acetylcholine receptors in mild Alzheimer\u2019s dementia","volume":"141","author":"Sabri","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.brainres.2025.149600_b0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jmhi.2014.01.001","article-title":"Beta-amyloid exhibits antagonistic effects on alpha 7 nicotinic acetylcholine receptors in orchestrated manner","volume":"8","author":"Sadigh-Eteghad","year":"2014","journal-title":"Journal of Medical Hypotheses and Ideas"},{"issue":"14","key":"10.1016\/j.brainres.2025.149600_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147890","article-title":"[18F]Flotaza for A\u03b2 Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer\u2019s Disease Brain Hippocampus and PET\/CT Imaging in 5xFAD Transgenic Mice","volume":"25","author":"Sandhu","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.brainres.2025.149600_b0260","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11064-005-6962-9","article-title":"Basal Forebrain Cholinergic Dysfunction in Alzheimer\u2019s Disease \u2013 Interrelationship with \u03b2-amyloid","volume":"30","author":"Schliebs","year":"2005","journal-title":"Inflammation and Neurotrophin Signaling. Neurochemical Research"},{"issue":"24","key":"10.1016\/j.brainres.2025.149600_b0265","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.3390\/molecules28248128","article-title":"Synthesis and evaluation of compound targeting \u03b17 and \u03b22 subunits in nicotinic acetylcholinergic receptor","volume":"28","author":"Singh","year":"2023","journal-title":"MOLECULES"},{"key":"10.1016\/j.brainres.2025.149600_b0270","doi-asserted-by":"crossref","unstructured":"Stage, E., Svaldi, D., Sokolow, S., Risacher, S. L., Marosi, K., Rotter, J. I., Saykin, A. J., Apostolova, L. G., & Initiative, for the A. D. N. (2021). Prescribing cholinesterase inhibitors in mild cognitive impairment\u2014Observations from the Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions, 7(1), e12168.","DOI":"10.1002\/trc2.12168"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-021-00954-w","article-title":"Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer\u2019s disease dementia","volume":"14","author":"Sultzer","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"4","key":"10.1016\/j.brainres.2025.149600_b0280","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jagp.2016.11.011","article-title":"Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging","volume":"25","author":"Sultzer","year":"2017","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"13","key":"10.1016\/j.brainres.2025.149600_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310808","article-title":"Comparison of Monoamine Oxidase-A, A\u03b2 Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer\u2019s Disease Brain","volume":"24","author":"Syed","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1016\/j.brainres.2025.149600_b0290","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3390\/molecules27092780","article-title":"Nicotinic acetylcholine receptors and microglia as therapeutic and imaging targets in Alzheimer\u2019s disease","volume":"27","author":"Takata","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.brainres.2025.149600_b0295","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nature Aging"},{"issue":"3","key":"10.1016\/j.brainres.2025.149600_b0300","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00259-020-05029-w","article-title":"(+)-[18F]Flubatine as a novel \u03b14\u03b22 nicotinic acetylcholine receptor PET ligand\u2014Results of the first-in-human brain imaging application in patients with \u03b2-amyloid PET-confirmed Alzheimer\u2019s disease and healthy controls","volume":"48","author":"Tiepolt","year":"2021","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1016\/j.brainres.2025.149600_b0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.brainres.2025.149600_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108008","article-title":"Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators","volume":"168","author":"Wilkerson","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_bib324","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1523\/JNEUROSCI.2484-21.2022","article-title":"Trapping of nicotinic acetylcholine receptor ligands assayed by in vitro cellular studies and in vivo PET imaging","volume":"43","author":"Zhang","year":"2023","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2025.149600_b0320","doi-asserted-by":"crossref","first-page":"12214","DOI":"10.1038\/s41598-022-16476-w","article-title":"Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia","volume":"12","author":"Zuin","year":"2022","journal-title":"Scientific Reports"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:57:45Z","timestamp":1777881465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"alternative-id":["S0006899325001593"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149600","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in [18F]Nifene Binding, a PET imaging Probe for \u03b14\u03b22* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer\u2019s disease brain","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149600"}}